Program - Interventional Oncology Sans Frontieres(IOSF
Transcription
Program - Interventional Oncology Sans Frontieres(IOSF
www.iosfc2016.org INTERVENTIONAL ONCOLOGY SANS FRONTIERES (IOSF) CONGRESS 2016 and 1st World Congress on FUSION IMAGING and AUGMENTED REALITY for Interventional Procedures Milan, Italy - July 7- 9, 2016 ATA Hotel Expo Fiera - Via Giovanni Keplero,12 Pero - MI ORGANIZING and SCIENTIFIC COMMITTEE: Luigi Solbiati S. Nahum Goldberg Franco Orsi Fusion Imaging and Augmented Reality SCIENTIFIC COMMITTEE: Giovanni Mauri Anastasios Michos Francesco DiMeco Francesco Prada Guido Torzilli Index Welcome Letter 3 Congress Map 4 Expo Area 5 Faculty 6 IOSF CME Credits Endorsements Organizing Secretariat Official Travel Agency 8 General Information 9 Scientific Program Thursday, July 7th 10 Scientific Program Friday, July 8th 13 Scientific Program Saturday, July 9th 15 Abstracts 17 Congress Venue How to reach Atahotel Expo Fiera 22 Main Sponsors 23 2 INTERVENTIONAL ONCOLOGY SANS FRONTIERES CONGRESS 2016 Dear Friends and Colleagues, Welcome to our Meeting “Interventional Oncology Sans Frontières” (IOSF) that follows the very successful previous Meeting in 2013 in Cernobbio (Como Lake). Our Organizing Committee, comprising the key world opinion leaders in this field, has particularly constructed the Meeting to be exciting and informative on multiple levels with many innovations and the participation of international colleagues. Luigi Solbiati, S. Nahum Goldberg, Franco Orsi for the IO Sans Frontières Organizing Committee Luigi SOLBIATI, MD S. Nahum GOLDBERG, MD, FSIR Franco ORSI, MD Professor of Radiology, Humanitas University and Research Hospital Rozzano (Milano), ITALY Vice-Chairman, Research, Director Image-guided Therapies and Tumor Ablation Dept. of Radiology Hadassah Hebrew University Med. Center Jerusalem, ISRAEL Chairman, Dept. of Interventional Radiology IEO European Institute of Oncology, Milano ITALY [email protected] [email protected] [email protected] [email protected] 3 Congress Map 4 INTERVENTIONAL ONCOLOGY SANS FRONTIERES CONGRESS 2016 Expo Area 5 Faculty Ahmed Muneeb (USA - Boston) Beth Israel Deaconess Medical Center de Baere Thierry (FRANCE - Paris) Institut Gustav Roussy Aliberti Camillo (ITALY - Padova) IRCCS Istituto Oncologico Veneto DiMeco Francesco (ITALY - Milano) Istituto Neurologico Besta Anselmetti Giovanni Carlo (ITALY - Milano) IEO European Institute of Oncology Donadon Matteo (ITALY - Rozzano - Milano) Humanitas University and Research Hospital Arai Yasuaki (JAPAN - Tokyo) National Cancer Center Hospital Fischer Thomas (GERMANY - Berlin) Ultrasound Research Laboratory of the Charité Campus Mitte Baek Jung Hwan (SOUTH KOREA - Seoul) Asan Medical Center Ulsan University Hospital Bale Reto (AUSTRIA - Innsbruck) University Clinic of Radiology Innsbruck Medical University Gadaleta Cosmo (ITALY - Bari) IRCCS Ospedale Oncologico Giovanni Paolo II Geschwind Jeff (USA - New Haven) Yale University School of Medicine Balzarini Luca (ITALY - Rozzano - Milano) Humanitas University and Research Hospital Gillams Alice (UK - London) The London Clinic Basso Curzio (ITALY - Genova) Camelot Biomedical Systems Giuliante Felice (ITALY - Roma) Policlinico Gemelli Bizzarri Giancarlo (ITALY - Albano Laziale - Roma) Ospedale Regina Apostolorum Golby Alexandra (USA - Boston) Brigham and Women’s Hospital Breen David (UK - Southampton) University Hospital of Southampton Goldberg Nahum (ISRAEL - Jerusalem) Hadassah Hebrew University Medical Center Brountzos Elias (GREECE - Athens) University of Athens Hasegawa Kiyoshi (JAPAN - Tokyo) Graduate School of Medicine, University of Tokyo Brown Karen T. (USA - New York) Memorial Sloan Kettering Cancer Center Helmberger Thomas (GERMANY - Munich) Klinikum Bogenhausen Burgmans Mark (NETHERLANDS - Leiden) LUMC, Leiden University Hospital Hinshaw Louis J. (USA - Madison ) Univ. of Wisconsin, School of Medicine and Public Health Cazzato Roberto Luigi (FRANCE - Strasbourg) Nouvel Hôpital Civil, Hôpitaux Universitaires de Strasbourg Jereczek Barbara Alicia (ITALY - Milano) IEO European Institute of Oncology Cerri Giovanni (BRAZIL - Sao Paulo) University of Sao Paulo Jung Ernst-Michael (GERMANY - Regensburg) University Hospital of Regensburg Chiti Arturo (ITALY - Rozzano - Milano) Humanitas University and Research Hospital Kelekis Alexis (GREECE - Athens) Attikon University Hospital Cianni Roberto (ITALY - Latina) Ospedale Santa Maria Goretti Lazzari Roberta (ITALY - Milano) IEO European Institute of Oncology Cillo Umberto (ITALY - Padova) Policlinico Universitario di Padova Lee Min Woo (SOUTH KOREA - Seoul) Samsung Medical Center Crocetti Laura (ITALY - Pisa) Azienda Ospedaliera Universitaria Cisanello Lever Alex (UK - London) Selex ES Curigliano Giuseppe (ITALY - Milano) IEO European Institute of Oncology Lewandowski Robert (USA - Chicago) Northwestern Medical Group 6 Malagari Katarina (GREECE - Athens) University of Athens Sardanelli Francesco (ITALY - San Donato M. - Milano) Policlinico San Donato Matei Victor (ITALY - Milano) IEO European Institute of Oncology Scorsetti Marta (ITALY - Rozzano - Milano) Humanitas University and Research Hospital Mauri Giovanni (ITALY - Milano) IEO European Institute of Oncology Selbekk Tormod (NORWAY - Trondheim) SINTEF Medical Technology Meloni Franca M. (ITALY - Milano) Casa di Cura Igea Shiina Shuichiro (JAPAN - Tokyo) Juntendo University Meng Zhiqiang (CHINA - Shanghai) Fudan Cancer Center Sofocleous Constantinos (USA - New York) Memorial Sloan Kettering Cancer Center Michos Anastasios (SWEDEN - Stockholm) Karolinska Institute Solbiati Luigi (ITALY - Rozzano - Milano) Humanitas University and Research Hospital Montorsi Marco (ITALY - Rozzano - Milano) Humanitas University and Research Hospital Solomon Steve (USA - New York) Memorial Sloan Kettering Cancer Center Narayanan Govindarajan (USA - Miami) University of Miami Steno Andrej (SLOVAKIA - Bratislava) University Hospital Bratislava Orecchia Roberto (ITALY - Milano) IEO European Institute of Oncology Strunk Holger (GERMANY - Bonn) University of Bonn Orsi Franco (ITALY - Milano) IEO European Institute of Oncology Torzilli Guido (ITALY - Rozzano - Milano) Humanitas University and Research Hospital Pece Salvatore (ITALY - Milano) IEO European Institute of Oncology van Strijen Marco (NETHERLANDS - Nieuwegein) St. Antonius Ziekenhuis Pedicini Vittorio (ITALY - Rozzano - Milano) Humanitas University and Research Hospital Viganò Luca (ITALY Rozzano - Milano) Humanitas University and Research Hospital Pereira Philippe (GERMANY - Heilbronn) SLK-Kliniken Wood Brad (USA - Bethesda) National Institutes of Health Perin Alessandro (ITALY - Milano) Istituto Neurologico Besta Zvi Ram (ISRAEL - Tel Aviv) Sourasky Medical Center Ping Liang (CHINA - Beijing) PLA General Hospital Corporate Speakers Poretti Dario (ITALY - Rozzano - Milano) Humanitas University and Research Hospital Prada Francesco (ITALY - Milano) Istituto Neurologico Besta Rhim Hyunchul (SOUTH KOREA - Seoul) Samsung Medical Center Richter Goetz M. (GERMANY - Stuttgart) Klinik für Diagnostische und Interventionelle Radiologie Tosoratti Nevio (HS - Hospital Service) Serra Piero (River Global Group) Solbiati Marco (Raw s.r.l) Gold Medal Awarded Ricke Jens (GERMANY - Magdeburg) DAfMT, Deutsche Akademie für Mikrotherapie Tito Livraghi (Italy - Vimercate Milano) Salem Riad (USA - Chicago) Northwestern University William Charboneau (USA Rochester - MN) Min-Hua Chen (China - Beijing) Santoro Armando (ITALY - Rozzano - Milano) Humanitas University and Research Hospital 7 IOSFC CME Credits The IOSFC 2016 will be accredited at the European Accreditation Council for medical Education (EACCME) and at the Italian Continuing Medical Education (CME) Disciplines accepted are: Physicians - Radiographers - Nurses The attendance to the sessions is verified through a magnetic badge combined with the Congress Badge. Assistants placed at the entrance will pass a reader on badge bar codes in order to scan entrance/exit to/from the Congress Simposia. Only participants who have attended the Congress and completed the IOSFC CME TEST will obtain CME/EACCME credit certificate. A system for Continuing Medical Education (CME) is aimed to assure a high level of theoretic and clinical competence throughout the working life of medical specialists. Doctors are faced with an exploding amount of literature and new technologies as well as a concern about escalating medical costs with a great emphasis on efficacy. CME provides educational activities, which allow to maintain, develop and increase medical knowledge and skill and to improve professional performances with the aim to ensure better and safer treatments for the patients. The UEMS European Union of Medical Specialists is representing 34 European Countries. The IOSFC was granted: 18.0 European CME credits by the European Accreditation for Continuing Medical Education (EACCME) 11.0 Italian CME credits by the Agenzia Nazionale per i Servizi Regionali (Age.Na.S.) Endorsements Organizing Secretariat ARSEDUCANDI Srl Viale Gian Galeazzo, 3 20136 Milano, ITALY Web: www.arseducandi.it e-mail: [email protected] Official Travel Agency PV Agency S.P.A Viale Gian Galeazzo, 3 20136 Milano, ITALY Web: www.pvagency.it 8 INTERVENTIONAL ONCOLOGY SANS FRONTIERES CONGRESS 2016 General Information Congress Registration EARLY BIRD RATE Until April 6th, 2016 From April 7th to June 7th, 2016 From June 8th to June 20th, 2016 Physician € 550,00 VAT INCLUDED € 700,00 VAT INCLUDED € 850,00 VAT INCLUDED Physician registered € 500,00 VAT INCLUDED to a Scientific Society* € 650,00 VAT INCLUDED € 800,00 VAT INCLUDED Radiographer / Nurse / €175,00 VAT INCLUDED Resident** € 225,00 VAT INCLUDED € 275,00 VAT INCLUDED Medical Student *** € 50,00 VAT INCLUDED € 50,00 VAT INCLUDED € 50,00 VAT INCLUDED Non-exhibiting Industries € 550,00 VAT INCLUDED € 700,00 VAT INCLUDED € 850,00 VAT INCLUDED Exhibiting Industries € 550,00 VAT INCLUDED € 700,00 VAT INCLUDED € 850,00 VAT INCLUDED One Day registration € 300,00 VAT INCLUDED € 300,00 VAT INCLUDED € 300,00 VAT INCLUDED Please note that an additional on-site fee of € 60,00 will be applied. Credit card payment only with Visa and Mastercard Cancellation will be accepted until June 19th, 2016 with refund of the amount paid - 50 euros (fee charge) * To benefit from membership fees, physicians must indicate in the Registration Form their Scientific Society of affiliation and membership number. ** Radiographer/Nurses and Resident (under the age of 35) must submit by e-mail or by fax a certificate signed by the Head of the Department and a copy of a valid ID together with their registration. *** Medical students (under the age of 27) must submit by e-mail or by fax a certificate of study and a copy of a valid ID together with their registration. Registration Fee Includes: - Admission to all scientific sessions (only for Physician) - Admission to scientific exhibition - Admission to technical exhibition - Congress materials - Certificate of attendance - Refreshment breaks and lunch daily - Social dinner 9 Scientific Program Thursday, July 7th 08:15 - 8:40 Registration 08:40 - 09:00 Welcome and Introduction 09:00 - 09:20 Keynote Lecture - Chairman: Nahum S. Goldberg 20 years of ablation: Past, present and future Organizing Committee Giovanni Cerri Steve Solomon State-Of-Art Of Technology Imaging - Chairmen: Luca Balzarini - Philippe Pereira 09:25 - 09:40 Cone beam technology: How did we ever work without it ? Marco van Strijen 09:40 - 09:55 CEUS for the guidance of thermal ablation: Current reliability and advancements Ernst-Michael Jung 09:55 -10:10 CEUS and TAE/TACE: A new “marriage” Dario Poretti 10:10 -10:20 Real-time ablation monitoring: Elastosonography makes the dream come true Laura Crocetti 10:20 - 10:35 MRI for guidance: How do I justify it ? Philippe Pereira 10:35 - 10:50 Imaging and follow-up: When and how ? Thomas Helmberger 10:50 - 11:00 DISCUSSION 11:00 - 11:10 COFFEE BREAK 11:10 - 11:30 Keynote Lecture: Chairman: Roberto Orecchia Cancer stem cells as a target for therapeutic intervention in cancer Salvatore Pece ABLATION - Chairmen: S. Nahum Goldberg - Marco Montorsi 11:30 - 12:00 RF vs MW: How do I choose ? * MW: In 2016 it’s the only way to go Franca Meloni * But I still love using Radiofrequency Alice Gillams 12:00 - 12:15 Microwave ablation - Is it living up to the hype ? J. Louis Hinshaw 12:15 - 12:30 Irreversible electroporation: State of the art Govindarajan Narayanan 12:30 - 12:45 HIFU: State of the art Franco Orsi 10 INTERVENTIONAL ONCOLOGY SANS FRONTIERES CONGRESS 2016 12:45 - 12:50 DISCUSSION 12:50 - 13:10 Keynote Lecture: Chairman: Marco Montorsi Systemic effects of ablation 13:15 - 13:55 S. Nahum Goldberg Lunch Symposium TECNOLOGIE AVANZATE V-IORT: new strategy for vertebral mets. The EIO experience Chairman: Franco Orsi 13:15 - 13:35 V-IORT: surgical approach Giancarlo Anselmetti 13:35 - 13:55 V-IORT: clinical indications Roberta Lazzari 1st WORLD MEETING on FUSION IMAGING and AUGMENTED REALITY for INTERVENTIONAL PROCEDURES FUSION IMAGING and NAVIGATION in INTERVENTIONAL ONCOLOGY Chairmen: Luigi Solbiati - Brad Wood 14:00 - 14:20 Navigation tools: An overview 14:20 - 15:10 Are they really useful for liver ablations ? 15:10 - 15:35 Brad Wood * The Italian experience Giovanni Mauri *The European experience Anastasios Michos * The Chinese experience Liang Ping * The Korean experience (S-Fusion) Min Woo Lee Extrahepatic applications * Virtual Navigation: Prostate, lung and neck Giancarlo Bizzarri * Prostate interventions with irreversible electroporation Thomas Fischer 15:35 - 15:45 Where will Fusion Imaging and Navigation be in 3 years ? 15:45 - 15:55 DISCUSSION 15:55 - 16:15 COFFEE BREAK 11 Luigi Solbiati FUSION IMAGING and NAVIGATION in NEUROSURGERY Chairmen: Francesco DiMeco - Zvi Ram 16:15 - 16:30 Multimodal visualization in interventional procedures Tormod Selbekk 16:30 - 16:45 Fusion imaging in neurosurgery Francesco Prada 16:45 - 17:00 3D navigated ultrasound Andrej Steno FUSION IMAGING and NAVIGATION in ABDOMINAL SURGERY Chairmen: Kiyoshi Hasegawa - Guido Torzilli 17:05 - 17:20 Fusion imaging and fluorescence for strategic surgical planning Kiyoshi Hasegawa 17:20 - 17:35 Fusion imaging for the surgical management of colorectal liver metastases Guido Torzilli 17:35 - 17:50 Fusion imaging as a tool for facilitating surgeons’ training in intraoperative navigation Matteo Donadon the FUTURE: INTEGRATED MULTIMODAL IMAGING, AUGMENTED REALITY and NOVEL PARADIGMS for INTERVENTIONAL TRAINING Chairmen: Francesco DiMeco - Francesco Prada 17:55 - 18:10 The AMIGO suite: A surgical innovation laboratory Alexandra Golby 18:10 - 18:50 - Intra-operative US simulation for neurosurgical training Curzio Basso - Simulation techniques: From high-tech aviation to Alex Lever high-risk surgery - New candidates’ selection and teaching paradigms in neurosurgery: Preliminary experience at the Besta NeuroSim Center 18:50 - 19:00 DISCUSSION and CONCLUSIONS 12 Alessandro Perin INTERVENTIONAL ONCOLOGY SANS FRONTIERES CONGRESS 2016 Friday, July 8 th CUTTING EDGE I O PRACTICE by ORGAN SYSTEM: Part 1 HCC: 20 years of thermal ablation - Chairmen: Constantinos Sofocleous - Guido Torzilli 08:30 - 08:45 RFA: Results and lessons learned Shuichiro Shiina 08:45 - 09:00 RFA: Still relevant for HCC ? Hyunchul Rhim 09:00 - 09:10 Can we raise the bar using Microwaves ? Franca Meloni Luigi Solbiati 09:10 - 09:25 Ablation for intermediate HCC: extending BCLC guidelines Reto Bale 09:25 - 09:40 Is BCLC therapeutic flow-chart still applicable ? Philippe Pereira 09:40 - 09:55 I O treatments in a Transplant Center Umberto Cillo 09:55 - 10:10 Evolving role of combination therapies S. Nahum Goldberg 10:10 - 10:20 DISCUSSION HEPATIC COLORECTAL METASTASES - Chairmen: Felice Giuliante - Armando Santoro 10:20 - 10:35 Conservative ablation Constantinos Sofocleous 10:35 - 10:50 Aggressive ablation Alice Gillams 10:50 - 11:05 Stereotactic body radiation therapy vs ablation Marta Scorsetti 11:05 - 11:15 DISCUSSION 11:15 - 11:35 COFFEE BREAK LUNG - Chairmen: Thierry De Baere - Barbara Alicia Jereczek 11:35 - 11:50 We can do quite a bit with ablation 11:50 - 12:05 We can do even better adding chemoembolization Cosmo Gadaleta 12:05 - 12:20 Radiation therapy is just fine, thank you 12:20 - 12:30 DISCUSSION 12:50 - 13:40 Lunch Symposium HOSPITAL SERVICE Steve Solomon Marta Scorsetti Next generation HS AMICA: the new ablation paradigm Chairman: Luigi Solbiati 12:50 - 13:15 The HS AMICA revolution: higher power, enhanced control, extended usability Nevio Tosoratti 13:15 - 13:40 Ablavision: taking ablation to a higher standard through pre-and post-treatment image processing Marco Solbiati 13 13:40 - 14:00 Keynote Lecture - Chairman: Franco Orsi TAE or TACE ? The ultimate answer ! Karen Brown THE ARTERIAL ROUTE TO THE TUMOR HCC - Chairmen: Elias Brountzos - Vittorio Pedicini 14:00 - 14:15 Conventional TACE: Why Asia does it better ? Yasuaki Arai 14:15 - 14:30 TACE 2.0: Eluting beads: The first generation Katerina Malagari 14:30 - 14:45 TACE 2.0: Eluting beads: The latest ! Goetz M. Richter 14:45 - 15:00 Beyond TACE: Do degradable starch microspheres Philippe Pereira put everything at stake ? 15:00 - 15:10 DISCUSSION RADIOEMBOLIZATION - Chairmen: Elias Brountzos - Dario Poretti 15:10 - 15:30 Y90RE or TACE: That is the question Robert Lewandowski 15:30 - 15:45 Do it superselectively or don’t bother Roberto Cianni 15:45 - 16:00 What’s new ? Lobar hypertrophy Robert Lewandowski 16:00 - 16:10 DISCUSSION 16:10 - 16:30 COFFEE BREAK METASTATIC LIVER - Chairmen: Giuseppe Curigliano - Robert Lewandowski 16:30 - 16:45 The DEBIRI affair: What you should know Camillo Aliberti 16:45 - 16:55 Integration of SIR-Spheres Y resin microspheres into the management of colorectal metastases Jens Ricke 16:55 - 17:10 Percutaneous hepatic chemoperfusion: Still alive ? Mark Burgmans 17:10 - 17:25 NET: The essential role of interventional radiologists Thierry de Baere 17:25 - 17:35 The “Humanitas protocol” for treatment of recurrence of mCRC after resection Luca Viganò 17:35 - 17:45 DISCUSSION 17:45 - 18:30 GOLD MEDAL PRESENTATIONS HONORING SEMINAL CONTRIBUTIONS TO INTERVENTIONAL ONCOLOGY Chairmen: Luigi Solbiati - S. Nahum Goldberg - Franco Orsi Italy: Tito Livraghi - United States: William Charboneau - China: Min-Hua Chen 90 14 INTERVENTIONAL ONCOLOGY SANS FRONTIERES CONGRESS 2016 Saturday, July 9th CUTTING EDGE I O PRACTICE by ORGAN SYSTEM: Part 2 KIDNEY and ADRENAL - Chairmen: Victor Matei - Muneeb Ahmed 08:45 - 09:00 20 years of RFA for renal cell carcinoma: Results and lessons learned Franco Orsi 09:00 - 09:15 Renal mass ablation: What is the case for cryo ? David Breen 09:15 - 09:30 Interventional Oncology for kidney familial disease Brad Wood 09:30 - 09:45 When to treat the adrenal gland Muneeb Ahmed 09:45 - 10:00 DISCUSSION 10:00 - 10:20 Keynote Lecture: Mechanistic basis for improved TACE techniques 10:20 - 10:40 COFFEE BREAK On streaming from Hong Kong Jeff Geschwind OTHER ORGANS - Chairman: Giovanni Carlo Anselmetti 10:40 - 11:00 What is the best way to ablate bone tumors ? 11:00 - 11:20 Expanding the role of I O in musculoskeletal procedures Alexis Kelekis Roberto L. Cazzato Chairman: Arturo Chiti 11:20 - 11:40 Breast cancer and ablation: What is the evidence ? Francesco Sardanelli 11:40 - 12:00 Ablation of thyroid cancers and cervical malignant adenopathies Jung Hwan Baek 12:00 - 12:15 DISCUSSION 12:15 - 12:35 Keynote Lecture: Chairman: Alexis Kelekis Debunking current myths in clinical trial design: Points of consideration for Interventional Radiology 12:35 - 13:15 Lunch Symposium RIVER GLOBAL HEALTHCARE Riad Salem US-Guided HIFU - Chairman: Holger Strunk 12.35 - 12.45 Introducing RGG Healthcare to the IR World Piero Serra 12.45 - 13.00 Do you really know the power of USgHIFU in Oncology? Franco Orsi 13.00 - 13.15 A real hope for pancreatic tumors Zhiqiang Meng 15 13:50 - 15:00 BEST ABSTRACTS AWARDS Chairmen: Luigi Solbiati - Nahum S. Goldberg - Franco Orsi 15:00 - 16:00 CLINICAL PEARLS Muneeb Ahmed Chairmen: Thomas Helmberger - Thierry deBaere Yasuaki Arai Thomas Helmberger 16:00 - 16:50 CASES I WISH I DID DIFFERENTLY Chairmen: Thomas Helmberger - Thierry de Baere 16:50 - 17:00 CONCLUSIONS 16 Roberto L. Cazzato Thierry de Baere INTERVENTIONAL ONCOLOGY SANS FRONTIERES CONGRESS 2016 Abstract 20 Thermal Ablation for Hepatocellular Carcinoma: A LargeScale Analysis of Long-term Outcome and Prognostic Factors China Jianmin Ding, Xiang Jing, Yandong Wang, Fengmei Wang,Yijun Wang 21 CT/MR-CEUS Image Fusion can Improve Thermal Ablation Effects of HCC by Immediately Assessing Treatment Response and Guiding Additional Ablation during the Ablation Procedures China Zhong-Zhen Su, Kai Li, Er-Jiao Xu, Rong-Qin Zheng 26 Clinical utility of imaging fusion combining CEUS and MRI in detection of HCCs undetectable by conventional ultrasound before radiofrequency ablation China Yi Dong, Wen-Ping Wang, Feng Mao, Zheng-Biao Ji, Hong Han, Bei-Jian Huang, 33 Local Therapy Combined with Sorafenib in the Treatment for Advanced Initial Recurrent Hepatocellular Carcinoma after Liver Resection China Manxia Lin, Baoxian Liu, Zhenwei Peng, Guangyan Wei, Zihao Dai, Ming Kuang 34 Thermal Ablation for Benign Thyroid Nodules: Microwave Ablation or Radiofrequency Ablation? China Hui-Xiong Xu, Wen-Wen Yue, Shu-Rong Wang, Feng Lu, Li-Ping Sun 36 Treatment of Recurrent Hepatocellular Carcinoma: Laparoscopic Surgery versus Radiofrequency Ablation in A Large Retrospective Comparative Multicenter Study Using Propensity Score Matching China Zhenwei Peng, Manxia Lin, Shuling Chen, Zihao Dai, Guangyan Wei, Ming Kuang 40 Location and number of tumors: potential risk factors of liver damage in thermal ablation China Yan Zhou, Jianming Ding, Xiang Jing 41 Efficacy of Single Dose Gonadotropin-Releasing Hormone Agonist Administration Prior to Magnetic Resonance-Guided Focused Ultrasound Surgery for Symptomatic Uterine Fibroids South Korea Sang-Wook Yoon 47 Transvaginal Ultrasound-guided Tru-cut Biopsy of Pelvic Masses: A Retrospective Study of 200 Cases China Xiao-Qing Pei, Shi-Yang Lin, Yong-Hong Xiong, Miao Yun, Wei Zheng, An-Hua Li 48 Percutaneous radiofrequency ablation (RFTA) of single lymphnode metastasis from hepatocellular carcinoma: initial experience Italy 49 Detection of residual tumors after ablation therapy: comparison of dynamic three-dimensional contrast-enhanced ultrasound and contrast-enhanced computed tomography China Yandong Wang, Xiang Jing, Jianmin Ding 53 The Value of Contrast-Enhanced Ultrasound for Optimizing Ultrasound-Guided Transthoracic Biopsy in Peripheral Pulmonary and Mediastinal Lesions China Song Wang, Wei Yang, Hui Zhang, Qian Xu, Kun Yan, Minhua Chen 54 Radiofrequency Ablation: Minimizing thermal injury to adjacent structures using a novel thermo-sensitive matrigel China Fu Jing-Jing, Yang Wei, Wang Song, Wu Wei, Yan Kun, Chen Min-Hua 55 Tumor Target Thermo-sensitive Liposomal Doxorubicin Enhances the Efficacy of Drugs Accumulation and Animal Survival China Wei Yang, Fei Yan, Song Wang, Jing-Jing Fu, Kun Yan, Hai-Rong Zheng, Min-Hua Chen 56 CT-guided microwave ablation and percutaneous screw fixation plus cementoplasty in the treatment of painful bone metastases. Preliminary experience. 17 Italy Mauro Mazzucco, Filippo Donelli, Pietro Cattaneo, Alessandro Vario, Bortolo Perin Pusceddu Claudio, Nicola Ballicu, Luca Melis 57 Endoscopic ultrasound-guided sampling using core biopsy needle for diagnosis of left lobe hepatocellular carcinoma in the cirrhosis background China Fen Chen, Tian’an Jiang 58 Real-time virtual navigation guided biopsy with US- PET/CT fusion imaging for metastasis in chest and abdominal wall: First experience China Tian’an Jiang, Fen Chen, Zhengdu Ye, Min Huang, Liyun Zhong, Guo Tian, Chao Chen 60 CT-guided percutaneous laser ablation of small lung cancer: a promising progress? China Guo Tian, Tian’an Jiang, Qiyu Zhao 63 Percutaneous laser ablation: a new contribution to unresectable metastatic retroperitoneal lesions? China Tian’an Jiang, Zhuang Deng, Fen Chen, Guo Tian, Baohua Wang 64 Percutaneous microwave thermoablation (MWTA) of kidney cancer up to 5 cm: long-term results Italy Mauro Mazzucco, Filippo Donelli, Antonino Calabrò, Pietro Cattaneo, Alessandro Vario, Lucia Anna Leone, Bortolo Perin 65 Personalized biomechanical modeling of prostate deformation based on elastography for MR-TRUS image registration China Ming Xu, Yi Wang, Chuan Peng, Xiao-Yan Xie 66 Shear wave elastography versus real-time elastography on evaluation the ablation zone of rabbit liver: A preliminary experimental study China Ming Xu, Xiao-Ju Li, Xiao-Er Zhang, Ming Liu, Xiao-Yan Xie 67 Combined radiofrequency ablation and ethanol injection versus hepatic resection for medium and large solitary hepatocellular carcinomas China Zhenwei Peng, Shuling Chen, Manxia Lin, Guangyan Wei, Zihao Dai, Ming Kuang 68 Clinical application in standardized treatment of radiofrequency ablation in intractable liver malignant tumor China Lihua Cheng, Zhongzhi Jia, Bobo Wu 72 The value of Intraoperative real-time planning in retroperitoneal metastasis tumor treated by 125I brachytherapy China Zhang Lijuan, Zhao Xianzhi, Zhang Hongtao, Wang Juan 73 The dosimetry study of 3D print template guided precision 125I seeds implantation China Zhang Hongtao, Di Xuemin, Yu Huimin, Zhao Xianzhi, Zhang Lijuan, Zhao Jinxin, Zhang Chen, Wang Juan 76 The preliminary efficacy of 125I seed implantation treated retroperitoneal lymph node metastasis of recurrent cervical cancer after radiotherapy China Di Xue-Min, Wang Ze-Yang, Ren Hong, Yang Sheng-Jun, Zhao Xian-Zhi,Yu Hui-Min, Zhang Hong-Tao, Wang Juan 79 The value of RFA in the treatment of large HCC adjacent to the diaphragm China Wei Wu, Kun Yan, Jung-Chieh Lee, Wei Yang, Zhong-Yi Zhang, Song Wang, Min-Hua Chen 80 Ten-year survival of hepatocellular carcinoma patients undergoing radiofrequency ablation as a first-line treatment China Min-Hua Chen, Wei Yang, Kun Yan, Wei Wu, Jung-Chieh Lee, Zhong-Yi Zhang, Song Wang 82 Radiofrequency Ablation of Liver Metastasis for the Treatment of Pancreatic Cancer: Analysis of Safety and Efficacy China Yong-qiang Hua, Jun-Hua Lin, Xiao-Yan Zhu, Ye-Hua Shen,Wang Peng, Zhi-Qiang Meng, Zhen Chen, Hao Chen 83 Mono-modality fusion imaging with ultrasound: Is it a better means to evaluate the therapeutic response of liver thermal ablation? China Erjiao Xu, Yinglin Long, Kai Li, Zhongzhen Su, Shumin Lv, Qingjin Zeng, Rongqin Zheng 87 Clinical application of ultrasound-guided radiofrequency ablation of Hepatocellular carcinoma nearby liver surface China Jin-Yu Wu, Shu-Zhi Lin,Wei Wu, Kun Yan, Quan Dai, Min-Hua Chen 88 Comparative study of the therapeutic outcome of percutaneous microwave coagulation therapy versus surgical resection for the treatment of primary single small hepatocellular carcinoma with cirrhosis China Hongchang Luo, Meng Gao, Wei Zhang, Ruobing Liu, Sansan Li, Zhiyong Hong, Kaiyan Li 89 A clinical study of thermal monitoring techniques of ultrasound guided microwave ablation for hepatocellular carcinoma in high risk locations China Han Zhi-Yu, Liang Ping, Yu Xiao-Ling, Cheng Zhi-Gang, Liu Fang-Yi, Yu Jie 18 93 A Three-dimensional Visualization Preoperative Treatment Fangyi Liu, Zhigang Cheng, Zhiyu Han, Xiaoling2016 Yu, INTERVENTIONAL ONCOLOGY SANS FRONTIERES CONGRESS Planning System for Microwave Ablation in Liver Cancer: China Mingan Yu, Ping Liang A Simulated Experimental Study 94 Long-term outcome of percutaneous ultrasound-guided radiofrequency ablation for colorectal liver metastases China Kun Yan, Zhongyi Zhang, Minhua Chen, Wei Wu, Wei Yang 96 Early assessment of the therapeutic response to radio frequency ablation for hepatic local lesion with 3-dimensional contrast-enhanced ultrasound (3D-CEUS) registration system: a preliminary study China Zhang Xiaoer, Xu Ming, Xie Xiaoyan, Cong Longfei, Sun Teng, Ye Jieyi, Lyu Mingde, Huang Guangliang 101 The influence of needle depth on the accuracy of the dose when 125I seeds implanted in malignant tumors guided by 3D print template China Yu Huimin, Zhang Hongtao, Zhao Xianzhi, Wang Zeyang, Zhao Jinxin, Di Xuemin, Wang Juan 102 Safety and efficacy evaluation of high intensity focused ultrasound (HIFU) in patients with advanced pancreatic cancer China Zhiqiang Meng, Kun Wang, Yehua Shen, Hao Chen, Zhen Chen 103 Survival Analysis for Unresectable Pancreatic Cancer Treated with Transcatheter Arterial Chemotherapy China Yehua Shen, Qi Qi, Peng Wang, Zhen Chen, Junhua Lin,Hao Chen, Zhiqiang Meng 105 The Assessment of Liver Ablation Using Two Dimensional Shear Wave Elastography China Xiaoyan Xie, Liya Su, Manxia Lin, Ming Xu, Ming Kuang, Mingde Lu 111 Comparison of cooled-probe microwave and radiofrequency ablation treatment in incipient hepatocellular carcinoma: a phase ? randomized controlled trial with 6-year follow-up China Yu Jie, Yu Xiao-Ling, Han Zhi-yu, Cheng Zhi-Gang, Liu Fang-Yi, Zhai Hong-Yan, Mu Meng-Juan, Liang Ping 113 Radiofrequency Ablation (RFA) using multiple-electrode switching system for unresectable medium-large Hepatocellular Carcinoma (HCC) nodules. Preliminary experience Italy Giampiero Francica, Alfonso Ragozzino, Federica Romano, Ettore Laccetti, Cristiano Giardiello, Mariano Scaglione 114 Ablation treatment of hepatocellular carcinoma (hcc) nodules under contrast-enhanced ultrasound (ceus) guidance. a multicenter study Italy Giampiero Francica, Maria Franca Meloni, Ilario de Sio, Maurizio Pompili, Eugenio Caturelli 117 Clinical study of correlation of blood perfusion characteristics in liver cancer by contrast-enhanced ultrasonography and individualized interventional therapy China 118 New candidates’ selection and teaching paradigms in neurosurgery: preliminary experience at the Besta NeuroSim Center Italy Alessandro Perin, Simone Nava, Sylvie Piacentini, Luca Mattei, Tommaso Galbiati, Michele Tassi, Dario Caldiroli, Francesco DiMeco 119 DEB-TACE with 40 micron drug eluting microspheres: early results Italy R. Nani, A. Pecorelli, A. Ragnanese, R. Agazzi, S. Sironi 120 US-Guided Core Biopsy of Lung Lesions Italy Roberto Nani, Anna Pecorelli, Gaetano Bonini, Silvia Pesenti, Sandro Sironi 121 Microwave Ablation (MWA) of Liver Tumors with Real Time US-CT/MRI Image Fusion/Virtual Needle-Track (US-CT/MRI fusion/VNT) Guiding. A Single Center Experience. Sweden Anastasios Michos, Thomas Josephson, Vitali Grozman, Evaldas Laurencikas 122 Irreversible Electroporation (IRE) of Liver Tumors with High Frequency Jet Ventilation (HFJV) and Real Time US-CT Image Fusion/Virtual Needle-Track (US-CTfusion/VNT) Guiding. A Single Center Experience. Sweden Anastasios Michos,Thomas Josephson, Vitali Grozman, Evaldas Laurencikas 123 Radiofrequency Ablation (RFA) of Kidney Tumors with High Frequency Jet Ventilation (HFJV) and Real Time US-CT Image Fusion/Virtual Needle-Track (US-CTfusion/VNT) Guiding. A Single Center Experience. Sweden Anastasios Michos, Thomas Josephson, Vitali Grozman, Evaldas Laurencikas 124 Percutaneous screw fixation and osteoplasty under CT-flouroscopy guidance in pathological fractures. Italy 19 SI Qin, Zhang Wenjie, Qian Xiaoli, Huang Shengxi, Li Zengcai Maria Cristina Fancello, Matteo Mammucari, Sergio Capece, Mariella Sorarù, Teodoro Sava, Ernesto Bissoli 125 Renal tumors with renal sinus extension: safety and effectivenes of image-guided thermal ablation Italy 126 Percutaneous ablation of renal cell carcinoma using a high power microwave system: focus upon safety and efficacy Greece Dimitrios Filippiadis, Argyro Mazioti, Georgios Velonakis, Chrysostomos Kostantos, Nikolaos Kelekis, Alexios Kelekis 127 Vertebral augmentation with the KIVA system in patients with symptomatic malignant fractures in the thoracic spine Greece Dimitrios Filippiadis, Georgios Velonakis, Chrysostomos Kostantos, Argyro Mazioti, Nikolaos Kelekis, Alexios Kelekis 128 Effect of tumor complexity on oncologic efficacy and complications in the percutaneous microwave ablation of T1a renal cell carcinoma USA Shane A. Wells, E. Jason Abel, Timothy J. Ziemlewicz, Sara L. Best,Meghan G. Lubner, Fred T. Lee Jr, J. Louis Hinshaw, USA Shane A. Wells, E. Jason Abel, Timothy J. Ziemlewicz, Sara L. Best,Meghan G. Lubner, Fred T. Lee Jr, J. Louis Hinshaw 129 Local oncologic efficacy and safety of percutaneous thermal ablation for metastatic renal cell carcinoma Luca Nicosia, Giovanni Mauri, Franco Orsi, Paolo della Vigna, Gianluca Maria Varano 130 Cryoablation or microwave ablation for localized T1a renal cell carcinoma: Local oncologic efficacy and distant tumor progression USA Shane A. Wells, E. Jason Abel, Timothy J. Ziemlewicz, Sara L. Best,Meghan G. Lubner, Fred T. Lee Jr, J. Louis Hinshaw 131 Can stereotactic body radiation therapy (SBRT) be an effective and viable therapeutic option for inoperable HCC? Results on 71 patients and 102 treated lesions. Italy Ciro Franzese,Tiziana Comito,Angelo Tozzi, Cristina Iftode, Anna Maria Ascolese, Fiorenza De Rose, Giuseppe Roberto D’Agostino, Marta Scorsetti 132 Phase II trial on SBRT for unresectable Liver Metastases: Long-term outcomes and prognostic factors of survival Italy Tiziana Comito, Lucia Di Brina, Ciro Franzese, Angelo Tozzi, Piera Navarria, Cristina Iftode, Davide Franceschini, Marta Scorsetti 134 Image-guided Radiofrequency Ablation of Lung tumours: Experience at a tertiary centre in Singapore Singapore 135 HIFU of Breast Fibroadenoma: a treat-and-resect case Italy Gabriele Levrini, Giuseppe Falco, Mauro Iori, Guglielmo Ferrari, Moira Ragazzi, Pierpaolo Pattacini 137 Ct-Guided rfa to treat osteoid osteoma: a 15-years experience at istituto ortopedico g.pini Italy Chiara De Angelis, Fabio Giardina, Stefano Bastoni, Primo Daolio, Matteo Precerutti, Francesco Sardanelli, Mauro Gallazzi, Giancarlo Arborio 138 Periprocedural morbidity in patients undergoing ablation of five or more lung metastases at a single treatment session UK Alice Gillams, Bill Lees 139 Ceus during and after tace in the management of patients with HCC Italy Gianpaolo Vidili, Fabio Claudio, Gianni Pes, Mario Maiore, Aldo Pischedda, Gianni Meloni, Delitala Giuseppe Apoorva Gogna, Leong Sum,Shaun Chan, Nandakumar, Richard Lo, Karthikeyan, Too Chow Wei, Farah Irani E-posters All accepted abstracts will be shown as e-Poster on a paperfree board instead of the traditional paper Poster. Every monitor, located next to the Conference Room Entrance is a station, where every participant will be able to: 1. Search for a poster using categories, topics, authors, title or abstract code 2. Watch the abstract presentation as a printed one on the monitor 3. Zoom in to see the details 4. Vote for one abstract of each of the 4 categories (Ablation - Transcatheter, Radiation Oncology and Bone Treatments - Imaging and Biopsy - Fusion) (Instructions available on site) Each abstract will be voted by the Scientific Committee and during the Congress by all the attendees - 3 BEST ABSTRACTS will be awarded during Friday night Social Dinner - The best 7 abstracts will be orally presented during the dedicated Saturday Session 20 INTERVENTIONAL ONCOLOGY SANS FRONTIERES CONGRESS 2016 Congress Venue Ata hotel Expo Fiera, the largest Hotel for conferences near Milan’s new exhibition centre (Fieramilano Rho/Pero) is designed and built with “art technology”. The Conference Centre, the common areas and bedrooms are all equipped with free Wi-Fi internet connection. The Hotel offers 450 rooms, including Superior, Executive, Deluxe, Junior Suite and Corner Suites, as well as 77 Residence-style apartments, all soundproofed, bright and some with balcony, offering every comfort. The restaurant, overlooking the park and its beautiful open-kitchen, the Lounge Bar, the Fitness Centre, a modern Business Centre and a large private parking area, complete the wide range of services. Address: Via Keplero, 12 - 20016 - Pero (Milan) Distances: Central Milan railway station: 12 km Malpensa Airport: 40 km Linate Airport: 40 km Orio al Serio Airport: 55 km Rho-Pero Exhibition Centre: 3 km Malpensa fiere Exhibition Centre: 30 km Parking: ATA hotel Expo Fiera has 400 parking lots with the following costs: € 5 half day € 8 all day € 12 H24 for people who stay overnight 21 How to reach Atahotel Expo Fiera From Central Station by public transport: from Central Station take the underground (MM2 Green line - Abbiategrasso) and stop at “Cadorna” station. From there change and take the underground line MM1, Red line direction Rho-Fiera and stop at “Molino Dorino” station. A shuttle service “from and to” the hotel to Molino Dorino station - will be available from 7.00 am to 12.00 am, on request. This service is free. We recommend to wait for our shuttle bus on the side of the station. Outside the shuttle bus service hours, we suggest to get off at Pero underground station, which is about 600 meters from the hotel. Walk into Via Olona, turn right into Via Pisacane and at the traffic lights turn left in via Keplero, the hotel is 100 meters on the right. From Linate Airport, by public transport: from Linate Airport take the bus No. 73 (domestic arrivals area) and get off in “San Babila” station. From there take the underground line MM1, Red line - direction Rho-Fiera and stop at “Molino Dorino” station. A shuttle service “from and to” the hotel to Molino Dorino station - will be available from 7.00 am to 12.00 am, on request. This service is free. We recommend to wait for our shuttle bus on the side of the station. Outside the shuttle bus service hours, we suggest to get off at Pero underground station, which is about 600 meters from the hotel. Walk into Via Olona, turn right into Via Pisacane and at the traffic lights turn left in via Keplero, the hotel is 100 meters on the right. From Malpensa Airport, by public transport: directly at the terminal is expected the service “Malpensa Express” (one every 30 minutes) that goes to Cadorna Station in about 45 minutes. From there take the underground line MM1, Red line - direction Rho-Fiera and stop at “Molino Dorino” station. A shuttle service “from and to” the hotel to Molino Dorino station - will be available from 7.00 am to 12.00 am, on request. This service is free. We recommend to wait for our shuttle bus on the side of the station. Outside the shuttle bus service hours, we suggest to get off at Pero underground station, which is about 600 meters from the hotel. Walk into Via Olona, turn right into Via Pisacane and at the traffic lights turn left in via Keplero, the hotel is 100 meters on the right. By car: the Pero Sud exit on the motorway SP11 “Gallaratese” Milano-Novara (Tangenziale Ovest exit) is only 300 meters away. 22 INTERVENTIONAL ONCOLOGY SANS FRONTIERES CONGRESS 2016 Main sponsors Sponsors Partner 23 Organizing Secretariat ARSEDUCANDI Srl Viale Gian Galeazzo, 3 20136 Milano, ITALY Web: www.arseducandi.it Congress Secretariat Information/General Telephone: + 39 02 58189.573 Fax: +39 02.58189.439 Email: [email protected] Official Travel Agency PV Agency S.P.A Viale Gian Galeazzo, 3 20136 Milano, ITALY Web: www.pvagency.it Hotel Accommodation Telephone: + 39 02 58189.545 Fax: +39 02.58189.432 Email: [email protected] Hotel Accommodation for Group Telephone: + 39 02 58189.548 Fax: +39 02.58189.431 Email: [email protected] Registration Telephone: + 39 02 58189.564 Fax: +39 02.58189.408 Email: [email protected] Group Registration Telephone: + 39 02 58189.571 Fax: +39 02.58189.471 Email:[email protected] Speakers Contact Telephone: + 39 02 58189.543 Fax: +39 02.58189.421 Email: [email protected] Abstract Handling Telephone: + 39 02 58189.552 Fax: +39 02.58189.428 Email: [email protected] Exhibition & Sponsors Telephone: + 39 02 58189.565 Fax: +39 02.58189.430 Email: [email protected]